Lawrence, KS, United States of America

Mallesh Beesu


Average Co-Inventor Count = 4.7

ph-index = 1


Company Filing History:


Years Active: 2019-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mallesh Beesu: Innovator in Toll-Like Receptor Modulation

Introduction

Mallesh Beesu is a prominent inventor based in Lawrence, KS (US). He has made significant contributions to the field of immunology through his innovative work on toll-like receptor modulators. With a total of 3 patents, Beesu is recognized for his advancements in human TLR8-selective agonists.

Latest Patents

Beesu's latest patents focus on human toll-like receptor modulators of general Formula (II). These disclosures provide insights into the structure and function of these modulators, which are crucial for advancing therapeutic strategies in immunology. The specific details of the formulations are defined within the patents, showcasing his expertise in this specialized area.

Career Highlights

Mallesh Beesu is affiliated with the University of Kansas Medical Center Research Institute. His work at this esteemed institution has allowed him to explore and develop innovative solutions in the realm of immunology. His research has the potential to impact various therapeutic applications, particularly in enhancing immune responses.

Collaborations

Beesu has collaborated with notable colleagues such as Sunil Abraham David and Giuseppe Caruso. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of research conducted.

Conclusion

Mallesh Beesu's contributions to the field of immunology through his patents and research at the University of Kansas Medical Center Research Institute highlight his role as an influential inventor. His work on toll-like receptor modulators is paving the way for future advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…